Age-related macular degeneration is a very common condition that is caused by a complex interplay of genetic and environmental factors. It is likely that, in the future, genetic testing will allow physicians to achieve better clinical outcomes by administering specific treatments to patients based on their genotypes. However, improved outcomes for genotyped patients have not yet been demonstrated in a prospective clinical trial, and as a result, the costs and risks of routine genetic testing currently outweigh the benefits for patients with age-related macular degeneration.
Stone EM. Genetic Testing for Age-Related Macular Degeneration: Not Indicated Now. JAMA Ophthalmol. 2015;133(5):598–600. doi:10.1001/jamaophthalmol.2015.0369
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: